A randomized phase II trial of weekly docetaxel plus either cisplatin or oxaliplatin in patients with previously untreated advanced gastric cancer: Preliminary results

被引：0
|
作者：
Sym, S.
Park, S.
Park, J.
Kwon, K.
Jung, I.
Cho, E.
Lee, W.
Chung, M.
Shin, D.
Lee, J.
机构：
[1] Gachon Univ, Gil Hosp, Inchon, South Korea
[2] Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4566
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Phase I/II trial of weekly docetaxel and carboplatin in previously untreated patients with advanced non-small cell lung cancer.
    Walsh, W
    Gordon, J
    Merolli, R
    Seidler, C
    Kasturi, V
    Finn, T
    Liu, Q
    Strauss, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 691S - 691S
  • [32] A phase II trial of weekly fractionated irinotecan and cisplatin for advanced gastric cancer
    Hei-Cheul Jeung
    Sun Young Rha
    Sung Hoon Noh
    Jae Kyung Roh
    Hyun Cheol Chung
    [J]. Cancer Chemotherapy and Pharmacology, 2007, 59 : 313 - 320
  • [33] A phase II trial of weekly fractionated irinotecan and cisplatin for advanced gastric cancer
    Jeung, Hei-Cheul
    Rha, Sun Young
    Noh, Sung Hoon
    Roh, Jae Kyung
    Chung, Hyun Cheol
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (03) : 313 - 320
  • [34] Updated results of a randomized phase II trial for neoadjuvant versus adjuvant docetaxel/cisplatin chemotherapy in patients with locally advanced gastric cancer.
    Kim, Young Woo
    Ryu, Keun Won
    Choi, Il Ju
    Kook, Myeong-Cherl
    Park, Young Iee
    Kim, Hark K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [35] Docetaxel and cisplatin in patients with advanced gastric cancer: results of Japanese phase I/II study
    Soh Saitoh
    Yuh Sakata
    [J]. Gastric Cancer, 2002, 5 (Suppl 1) : 23 - 26
  • [36] Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer
    Millward, MJ
    Zalcberg, J
    Bishop, JF
    Webster, LK
    Zimet, A
    Rischin, D
    Toner, GC
    Laird, J
    Cosolo, W
    Urch, M
    Bruno, R
    Loret, C
    James, R
    Blanc, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) : 750 - 758
  • [37] Treatment of Patients with Advanced Biliary Tract Cancer with Either Oxaliplatin, Gemcitabine, and Capecitabine or Cisplatin and Gemcitabine-A Randomized Phase II Trial
    Markussen, Alice
    Jensen, Lars Henrik
    Diness, Laura Vittrup
    Larsen, Finn Ole
    [J]. CANCERS, 2020, 12 (07) : 1 - 10
  • [38] A phase I/II trial of docetaxel (D) and oxaliplatin (O) in patients with advanced gastric cancer (AGC)
    Park, Y.
    Kim, K.
    Choi, M.
    Hong, J.
    Lee, E.
    Park, M.
    Kim, H.
    Lee, Y.
    Park, J.
    Lim, H.
    Kang, W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [39] Phase II trial of a biweekly regimen of fluorouracil and leucovorin plus irinotecan (Folfiri) in patients with previously untreated advanced gastric cancer
    Cordio, S.
    Rosati, G.
    Caputo, G.
    Condorelli, S.
    Germano, D.
    Mattina, M.
    Amadio, P.
    Reggiardo, G.
    Bordonaro, R.
    Manzione, L.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 22 - 22
  • [40] Phase I trial of weekly docetaxel with a 4-weekly cisplatin administration in patients with advanced gastric carcinoma
    Polyzos, A
    Syrigos, K
    Stergiou, J
    Panopoulos, C
    Potamianou, A
    Vamvakas, L
    Georgoulias, V
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 55 (05) : 466 - 470
12345